People often skip neurological meds when out-of-pocket costs rise - (This is Money via NewsPoints Desk)

  • According to study findings published in the journal Neurology, patients with some common neurological disorders are more likely to forgo their medication when out-of-pocket drug costs rise, as reported by This is Money.

  • "Even changes as small as $50 a month can make a difference," commented coauthor Brian Callaghan.

  • Researchers analyzed 15 years' worth of information in a private insurance claims database, focusing on 19,820 patients with Alzheimer's disease, 3130 with Parkinson's disease, and 57,495 with peripheral neuropathy.

  • For each condition, pairs of drugs were compared. While the effectiveness and side effects of each drug in the pair were similar, one came with a higher out-of-pocket cost. Investigators looked at how many days' worth of the drugs were supplied to each person in the first six months after it was prescribed to them.

  • They found that $50 increases in out-of-pocket costs for Alzheimer's disease drugs were associated with a 12% lower rate of prescriptions being filled.

  • Similarly, a $50 increase in costs for peripheral neuropathy drugs led to a 9% lower rate of prescriptions getting filled, although they didn't find a statistically meaningful difference in results for Parkinson's disease medications.

To read more NewsPoints articles, click here.